1. Home
  2. ARQT vs OSW Comparison

ARQT vs OSW Comparison

Compare ARQT & OSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARQT
  • OSW
  • Stock Information
  • Founded
  • ARQT 2016
  • OSW 2017
  • Country
  • ARQT United States
  • OSW Bahamas
  • Employees
  • ARQT N/A
  • OSW N/A
  • Industry
  • ARQT Biotechnology: Pharmaceutical Preparations
  • OSW Hotels/Resorts
  • Sector
  • ARQT Health Care
  • OSW Consumer Discretionary
  • Exchange
  • ARQT Nasdaq
  • OSW Nasdaq
  • Market Cap
  • ARQT 1.6B
  • OSW 1.7B
  • IPO Year
  • ARQT 2020
  • OSW N/A
  • Fundamental
  • Price
  • ARQT $13.52
  • OSW $18.84
  • Analyst Decision
  • ARQT Strong Buy
  • OSW Strong Buy
  • Analyst Count
  • ARQT 6
  • OSW 5
  • Target Price
  • ARQT $18.80
  • OSW $19.60
  • AVG Volume (30 Days)
  • ARQT 2.1M
  • OSW 770.5K
  • Earning Date
  • ARQT 05-06-2025
  • OSW 04-30-2025
  • Dividend Yield
  • ARQT N/A
  • OSW 0.85%
  • EPS Growth
  • ARQT N/A
  • OSW 84.76
  • EPS
  • ARQT N/A
  • OSW 0.63
  • Revenue
  • ARQT $212,819,000.00
  • OSW $903,423,000.00
  • Revenue This Year
  • ARQT $57.99
  • OSW $7.70
  • Revenue Next Year
  • ARQT $41.24
  • OSW $8.41
  • P/E Ratio
  • ARQT N/A
  • OSW $29.56
  • Revenue Growth
  • ARQT 100.03
  • OSW 9.80
  • 52 Week Low
  • ARQT $6.99
  • OSW $14.21
  • 52 Week High
  • ARQT $17.75
  • OSW $23.01
  • Technical
  • Relative Strength Index (RSI)
  • ARQT 42.59
  • OSW 62.25
  • Support Level
  • ARQT $12.42
  • OSW $17.85
  • Resistance Level
  • ARQT $15.67
  • OSW $18.75
  • Average True Range (ATR)
  • ARQT 0.87
  • OSW 0.69
  • MACD
  • ARQT -0.03
  • OSW 0.25
  • Stochastic Oscillator
  • ARQT 33.69
  • OSW 90.56

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

About OSW OneSpaWorld Holdings Limited

OneSpaWorld Holdings Ltd is an operator of health and wellness centers onboard cruise ships and an operator of health and wellness centers at destination resorts all over the world. It offers a suite of premium health, fitness, beauty, and wellness services and products. The services provided by the company include body, salon, and skin care services and products, fitness classes and personal fitness training and pain management, detoxifying programs, and comprehensive body composition analyses among others. The company has only one single segment of Maritime and Destination Resorts.

Share on Social Networks: